Table 3 Treatment outcomes of patients with CRAB and COS -AB pneumonia.

From: The prevalence, presentation and outcome of colistin susceptible-only Acinetobacter Baumannii-associated pneumonia in intensive care unit: a multicenter observational study

 

CRAB (n = 496)

CSO AB (n = 79)

P value

Mortality (since pneumonia onset)

Day 7, n (%)

72 (14.5)

8 (10.1)

0.383

Day 14, n (%)

104 (21.0)

21 (26.6)

0.329

Day 28, n (%)

156 (31.5)

27 (34.2)

0.724

In-hospital mortality, n (%)

230 (46.4)

36 (45.6)

0.991

Favorable clinical outcomes

Day 7

260 (52.4)

52 (65.8)

0.036

Day 14

260 (52.4)

43 (54.4)

0.833

Day 28

257(51.8)

37 (46.8)

0.483

Microbiological eradication

Day 7

49 (18.0)

6 (13.0)

0.539

Day 14

131 (40.3)

22 (36.7)

0.700

Day 28

172 (50.0)

28 (47.5)

0.826

28-day ventilator weaning, n (%)

232 (46.8)

40(50.6)

0.375

Newly onset dialysis, n (%)

46(9.3)

4(5.1)

0.308

Length of ICU stay (days), M (R)

19(1–163) (n = 266)

27(6–80) (n = 43)

0.043a

Length of hospital stay (days), M (R)

51 (8–284) (n = 266)

55 (14–132) (n = 43)

0.667a

Length of stay before pneumonia index day (days), M (R)

9 (0–121) (n = 266)

8 (0–71) (n = 43)

0.894a

Length of stay after pneumonia index day (days), M (R)

35 (3–196) (n = 266)

41 (13–86) (n = 43)

0.597a

  1. The analysis of the length of hospital and ICUICU and hospital stays, and length of stay before and after pneumonia index day did not include patients who expired during hospitalization.
  2. M (R) median (range).
  3. Significant values are given in bold.
  4. aMann-Whitney U test.
Back to article page